1-3 of 3
Jean-Marie Boher, PhD
Close
Sort by
Journal Articles

Allogeneic Stem Cell Transplantation From Matched Related Donor in Patients Over the Age of 55 Years: A Prospective Multicenter Phase II Study of a Reduced Intensity Conditioning Associating Fludarabin-IV Busulfan and Thymoglobulin

Didier Blaise, MD, Mohamad Mohty, Noel Milpied, MD, Anne Gaelle Lecorroller, PhD, Nathalie Fegueux, Sabine Furst, MD, Patrice Chevallier, MD, Reza Tabrizi, MD, Mauricette Michallet, MD, PhD, Jean Yves Cahn, MD, Anne Sirvent, MD, Jacques-Olivier Bay, MD, PhD, Jean El Cheikh, MD, PhD, Catherine Faucher, MD, Roberto Crocchiolo, MD, Agnes Boyer-Chamard, MD, Luca Castagna, MD, Jean Marie Boher, PhD
Journal: Blood
Blood (2011) 118 (21): 1952.
https://doi.org/10.1182/blood.V118.21.1952.1952
Published: 2011
Journal Articles

Impact of the New Anti-Myeloma Drugs on Outcome of Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with High-Risk Multiple Myeloma

Jean El-Cheikh, MD PhD, Roberto Crocchiolo, MD, Jean Marie Boher, PhD, Sabine Furst, MD, Anne Marie Stoppa, Catherine Faucher, MD, Luca Castagna, MD, Angela Granata, Claire Oudin, jean Marc schiano De Colella, Diane Coso, MD, Reda Bouabdallah, MD, Didier Blaise, MD
Journal: Blood
Blood (2011) 118 (21): 4456.
https://doi.org/10.1182/blood.V118.21.4456.4456
Published: 2011
Journal Articles

Prospective Randomized Comparison of Reduced Intensity (FLU-BU-ATG) and Non-Myeloablative (FLU-TBI) Conditioning for Genoidentical Allo-SCT: a Clinical and economical Multicenter Itac Study.

Didier Blaise, Reza Tabrizi, Anne-Gaelle Le Corroller-Soriano, Mauricette Michallet, MD, PhD, Jacques-Olivier Bay, MD, PhD, Mohamad Mohty, MD, PhD, Catherine Faucher, MD, Sabine Furst, MD, Noel Milpied, MD, PhD, Luca Castagna, MD, Christian Chabannon, MD, PhD, Agnes Boyer, MD, Jean-Marie Boher, PhD
Journal: Blood
Blood (2009) 114 (22): 193.
https://doi.org/10.1182/blood.V114.22.193.193
Published: 2009